MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. (Q50953133)

26 March 2018

title

MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. (English)

1 reference

26 March 2018

author name string

Tongbao Feng

1

1 reference

26 March 2018

Dongqin Xu

2

1 reference

26 March 2018

Chao Tu

3

1 reference

26 March 2018

Wenjing Li

4

1 reference

26 March 2018

Yongling Ning

5

1 reference

26 March 2018

Jun Ding

6

1 reference

26 March 2018

Shizhong Wang

7

1 reference

26 March 2018

Liudi Yuan

8

1 reference

26 March 2018

Ning Xu

9

1 reference

26 March 2018

Keqing Qian

10

1 reference

26 March 2018

Yong Wang

11

1 reference

26 March 2018

Chunjian Qi

12

1 reference

26 March 2018

publication date

3 March 2015

1 reference

26 March 2018

published in

Tumor Biology

1 reference

26 March 2018

volume

36

1 reference

26 March 2018

issue

8

1 reference

26 March 2018

page(s)

5987-5997

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3275-8

exact match

0 references

cites work

Cancer statistics for African Americans, 2013.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Breast cancer metastasis: a microRNA story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA function: multiple mechanisms for a tiny RNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA in cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA-based therapeutics for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

A microRNA array reveals extensive regulation of microRNAs during brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

miR-124 radiosensitizes human glioma cells by targeting CDK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MiR-124 retards bladder cancer growth by directly targeting CDK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Requirement for CDK4 kinase function in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

The requirement for cyclin D function in tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

A functional study of miR-124 in the developing neural tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3275-8

Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry

21 January 2018

1 reference

12 December 2020

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

1 reference

12 December 2020

The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.

1 reference

12 December 2020

Breast cancer statistics, 2013.

1 reference

12 December 2020

CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines

1 reference

12 December 2020

Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.

1 reference

12 December 2020

10.1007/S13277-015-3275-8

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

25731732

1 reference

26 March 2018